Cantor Fitzgerald’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.2M Sell
553,688
-535,932
-49% -$14.4M 0.21% 65
2026
Q1
$22.6M Sell
1,089,620
-361,826
-25% -$8.55M 0.33% 53
2025
Q4
$47.1M Buy
1,451,446
+592,842
+69% +$25.4M 0.72% 42
2025
Q3
$48.7M Buy
858,604
+750,907
+697% +$38.5M 0.47% 44
2025
Q2
$5.37M Buy
107,697
+91,438
+562% +$4.13M 0.1% 56
2025
Q1
$480K Buy
+16,259
New +$604K 0.01% 157
2023
Q4
Sell
-26,250
Closed -$165K 381
2023
Q3
$165K Buy
+26,250
New +$195K ﹤0.01% 446

Other funds holding HIMS

Cantor Fitzgerald's HIMS Position: Q2 2026 in Review

Cantor Fitzgerald reduced its Hims & Hers Health (HIMS) stake by 49% in Q2 2026, selling an estimated $14.4M and leaving 553,688 shares worth $19.2M. The position accounts for 0.21% of the portfolio, ranked #65.

Cantor Fitzgerald first reported a position in HIMS in Q3 2023 and has held it in 7 quarters since. The position peaked at $48.7M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Cantor Fitzgerald held 553,688 shares of Hims & Hers Health worth $19.2M as of Q2 2026.
  • Cantor Fitzgerald sold 535,932 Hims & Hers Health shares in Q2 2026, an estimated $14.4M.
  • Hims & Hers Health made up 0.21% of Cantor Fitzgerald's portfolio in Q2 2026, its #65 holding.
  • Cantor Fitzgerald first reported a position in Hims & Hers Health in Q3 2023 and has held it in 7 quarters since.
  • Cantor Fitzgerald's Hims & Hers Health position peaked at $48.7M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Cantor Fitzgerald's 13F filing for Q2 2026, filed 14 Aug 2026.